Publication:
Association between sarcoidosis, pulse wave velocity, and other measures of subclinical atherosclerosis: a systematic review and meta-analysis

dc.contributor.authorWai Chung Yongen_US
dc.contributor.authorAnawin Sanguankeoen_US
dc.contributor.authorSikarin Upalaen_US
dc.contributor.otherThe University of Chicagoen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherBaystate Franklin Medical Centeren_US
dc.contributor.otherThe Johns Hopkins School of Medicineen_US
dc.date.accessioned2019-08-23T11:42:21Z
dc.date.available2019-08-23T11:42:21Z
dc.date.issued2018-10-01en_US
dc.description.abstract© 2017, International League of Associations for Rheumatology (ILAR). Chronic inflammation from autoimmune diseases has shown to be a risk factor for atherosclerosis, subsequently leading to cardiovascular disease. Endothelial dysfunction is the early pathogenesis of atherosclerosis in chronic inflammation, but the risk of atherosclerosis in sarcoidosis is less well defined. This meta-analysis aimed to explore the association of subclinical atherosclerosis and arterial stiffness in sarcoidosis. A comprehensive search of the MEDLINE and EMBASE databases was performed from date of inception through August 2017. The inclusion criterion was observational studies evaluating the association between sarcoidosis, subclinical atherosclerosis, and arterial stiffness by measuring pulse wave velocity (PWV). Definitions of sarcoidosis and methods to assess PWV were recorded for each study. The pooled standardized mean difference (SMD) of PWV and 95% confidence interval (CI) was calculated using a random-effects meta-analysis. The between-study heterogeneity of effect size was quantified using the Q statistic and I 2 . Data were extracted from five observational studies involving 499 subjects. Pooled result demonstrated a significant increase in PWV in patients who have sarcoidosis compared with controls (SMD = 0.57 m/s; 95% CI 0.21–0.92, p value = 0.002, I 2 = 75%, P heterogeneity < 0.01). After excluding studies with low or moderate quality, there was an increase in PWV in sarcoidosis compared with controls (SMD = 0.29 m/s; 95% CI 0.00–0.57, p value = 0.05, I 2 = 55%, P heterogeneity = 0.08). Our study suggests that sarcoidosis is associated with increased arterial stiffness and therefore at risk of subclinical atherosclerosis. Prospective study is required to investigate the association of subclinical atherosclerosis causing overt cardiovascular disease in patients with sarcoidosis.en_US
dc.identifier.citationClinical Rheumatology. Vol.37, No.10 (2018), 2825-2832en_US
dc.identifier.doi10.1007/s10067-017-3926-9en_US
dc.identifier.issn14349949en_US
dc.identifier.issn07703198en_US
dc.identifier.other2-s2.0-85034850763en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/46299
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85034850763&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleAssociation between sarcoidosis, pulse wave velocity, and other measures of subclinical atherosclerosis: a systematic review and meta-analysisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85034850763&origin=inwarden_US

Files

Collections